Genzyme Targets Anchen Over Hectorol ANDA
Genzyme Corp. has filed a patent infringement suit against Anchen Pharmaceuticals Inc. in an effort to block a generic version of renal disease treatment Hectorol from being brought to market....To view the full article, register now.
Already a subscriber? Click here to view full article